| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 54 |
| 1 | METHOTREXATE SODIUM | 53 |
| 2 | METHOTREXATE | 47 |
| 3 | INFLIXIMAB | 32 |
| 4 | RITUXIMAB | 31 |
| 5 | PREDNISOLONE | 26 |
| 6 | PREDNISOLONE ORAL | 26 |
| 7 | PREDNISOLONE ORAL SOLUTION | 26 |
| 8 | ADALIMUMAB | 25 |
| 9 | METHYLPREDNISOLONE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALOE FEROX LEAF | 1 | 0.0055 |
| 1 | VERICIGUAT | 1 | 0.0010 |
| 2 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 3 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| 4 | RITUXIMAB-ABBS | 3 | 0.0006 |
| 5 | BRODALUMAB | 1 | 0.0005 |
| 6 | SOTALOL HYDROCHLORIDE TABLES AF | 1 | 0.0004 |
| 7 | SOTALOL HYDROCHLORIDE TABLETS AF | 1 | 0.0004 |
| 8 | ADALIMUMAB-AATY | 19 | 0.0004 |
| 9 | ADALIMUMAB-FKJP | 17 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 88 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 49 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 47 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 33 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 26 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 6 | Alkylating Drug [EPC] | 15 |
| 7 | Loop Diuretic [EPC] | 15 |
| 8 | Benzodiazepine [EPC] | 14 |
| 9 | Aldosterone Antagonist [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 2 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 3 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 47 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 33 | 0.0001 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 11 | 0.0001 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |